Orrin Hatch on Stem Cell Research

Last Updated : Apr 28, 2010

Voting Record

Hope Offered through Principled and Ethical Stem Cell Research

The final piece of legislation was dubbed the "HOPE" Act and was voted on the same day. The Hope Act (S30) shared many of the same parameters as the the Stem Cell Research Act, in that it mostly ensured that no new stem cells be created for the sole purpose of using them in research. The bill also ensured that no embryos be damaged in research. Orrin Hatch voted in favor of the Hope Offered through Principled and Ethical Stem Cell Research.

Orrin Hatch voted in favor of the Hope Offered through Principled and Ethical Stem Cell Research.

Stem Cell Research Enhancement Act of 2007

In April of 2007, two more stem cell related bills were voted on in the Senate. The Stem Cell Research Enhancement Act of 2007 (S5) passed with support from a vast majority of Democratic Senators and about 1/3 of the Republican Senators. The legislation required (among other things) that any research done on stem cells involve only those which already existed. Orrin Hatch voted in favor of the Stem Cell Research Enhancement Act of 2007

Orrin Hatch voted in favor of the Stem Cell Research Enhancement Act of 2007

Stem Cell Research Enhancement Act

In July of 2006, the Senate passed the Stem Cell Research Enhancement Act. This legislation would have allowed research on human embryonic stem cells created after President Bush's 2001 deadline. The measure passed the House and Senate, but was vetoed. It passed the Senate 63-37. Orrin Hatch voted in favor of the Stem Cell Research Enhancement Act.

Orrin Hatch voted in favor of the Stem Cell Research Enhancement Act.

Alternative Pluripotent Stem Cell Therapies Enhancement Act

In July of 2006, the Senate voted unanimously to pass the Alternative Pluripotent Stem Cell Therapies Enhancement Act S 2754. The bill required the Secretary of Health and Human Services to do the following three tasks: provide guidance concerning the next steps required for additional research; prioritize research with the greatest potential for near-term clinical benefit; and take into account techniques outlined by the President\'s Council on Bioethics and any other appropriate techniques and research. Orrin Hatch voted in favor of the Alternative Pluripotent Stem Cell Therapies Enhancement Act

Orrin Hatch voted in favor of the Alternative Pluripotent Stem Cell Therapies Enhancement Act

 

Sponsored and Cosponsored Legislation

Session-111; Bill Number-S 487; Stem Cell Research Enhancement Act of 2009 - Cosponsor

Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the needs of the individuals seeking such treatment; (2) prior to donation, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking fertility treatment donated the embryos with written informed consent and received no financial or other inducements. Requires the Secretary to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

Session-111; Bill Number-S 3751; Stem Cell Therapeutic and Research Reauthorization Act of 2010 - Prime Sponsor

Amends the Stem Cell Therapeutic and Research Act of 2005 to revise provisions related to the National Cord Blood Inventory (the Inventory), including to establish an inventory goal of at least 150,000 new units of cord blood to be made available under the C.W. Bill Young Cell Transplantation Program (the Program).

Session-110; Bill Number-S 5; Stem Cell Research Enhancement Act of 2007 - Cosponsor

Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following ethical requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics for the purpose of fertility treatment and were in excess of the needs of the individuals seeking such treatment; (2) the embryos would never be implanted in a woman and would otherwise be discarded; and (3) such individuals donate the embryos with written informed consent and receive no financial or other inducements.

Session-109; Bill Number-S 471; Stem Cell Research Enhancement Act of 2005 - Cosponsor

A bill to amend the Public Health Service Act to provide for human embryonic stem cell research.

Session-109; Bill Number-S 876; Human Cloning Ban and Stem Cell Research Protection Act of 2005 - Prime Sponsor

A bill to prohibit human cloning and protect stem cell research.

User Comments